MiR-873 regulates ERα transcriptional activity and tamoxifen resistance via targeting CDK3 in breast cancer cells-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

MiR-873 regulates ERα transcriptional activity and tamoxifen resistance via targeting CDK3 in breast cancer cells

Published:2014-12-22 Issue:30 Volume:34 Page:3895-3907
ISSN:0950-9232
Container-title:Oncogene
language:en
Short-container-title:Oncogene

Author:

Cui J,Yang Y,Li H,Leng Y,Qian K,Huang Q,Zhang C,Lu Z,Chen J,Sun T,Wu R,Sun Y,Song H,Wei X,Jing P,Yang X,Zhang C

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Genetics,Molecular Biology

Link

http://www.nature.com/articles/onc2014430.pdf

Reference55 articles.

1. Clemons M, Goss P . Estrogen and the risk of breast cancer. N Engl J Med 2001; 344: 276–285.

2. Yager JD, Davidson NE . Estrogen carcinogenesis in breast cancer. N Engl J Med 2006; 354: 270–282.

3. Thomas C, Gustafsson JA . The different roles of ER subtypes in cancer biology and therapy. Nat Rev Cancer 2011; 11: 597–608.

4. Klinge CM . Estrogen receptor interaction with estrogen response elements. Nucleic Acids Res 2001; 29: 2905–2919.

5. Green KA, Carroll JS . Oestrogen-receptor-mediated transcription and the influence of co-factors and chromatin state. Nat Rev Cancer 2007; 7: 713–722.

Cited by 73 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Dual-target inhibitors based on ERα: Novel therapeutic approaches for endocrine resistant breast cancer;European Journal of Medicinal Chemistry;2024-04

2. Norcantharidin in cancer therapy – a new approach to overcoming therapeutic resistance: A review;Medicine;2024-03-01

3. Structural basis of CDK3 activation by cyclin E1 and inhibition by dinaciclib;Biochemical and Biophysical Research Communications;2023-06

4. Molecular Mechanisms of Anti-Estrogen Therapy Resistance and Novel Targeted Therapies;Cancers;2022-10-24

5. A review on the role of cyclin dependent kinases in cancers;Cancer Cell International;2022-10-20

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3